Special Organic Colloquium – Prof. Herman O. Sintim
Novel chemotypes of kinase inhibitors for the potential treatment of recurrent cancers Abstract: Therapeutic resistance remains a critical issue in cancer treatment. While cancer patients who harbor dysregulated protein kinases benefit from the use of kinase inhibitors (KIs), many fail therapy and almost all patients become resistant to treatment, indicating a critical unmet need to […]